Research shows that involving pharmacists in blood pressure management can improve medication adherence and blood pressure control. However, many studies on this topic have been criticized for various reasons, including involving few minority patients. To date, no randomized clinical trials have focused on barriers to medication adherence and blood pressure control among black patients with hypertension in community-based chain pharmacies.
What is added by this document?
The authors assessed the effectiveness and sustainability of a 6-month intervention in community chain pharmacies for black patients with hypertension, called Team Education and Adherence Monitoring (TEAM). Trained pharmacist-technician teams implemented the intervention using scheduled visits, Brief Medication Questionnaires, and toolkits to improve medication adherence and aid pharmacists in communicating feedback to patients and doctors.
Compared with participants in a control group who only received patient information, TEAM participants achieved greater improvement in refill adherence, systolic blood pressure levels, and blood pressure control (see table) . The authors also found a dose-response relationship: Patients who received the full intervention achieved more prolonged improvement in refill adherence, systolic blood pressure, and blood pressure control than those who did not complete the full intervention-and even partial participants achieved more sustained improvement than those in the control group.
Refill
What are the applications for these findings?
These findings suggest that good refill adherence is (1) sustainable, (2) linked to systolic blood pressure reduction and blood pressure control in black patients, and (3) pressure control given their knowledge and skills, access to refill records, presence in convenient locations, and ability to successfully implement a new model and tools in busy settings.
The approach used in TEAM may contribute to further research and ongoing efforts to improve care for black patients with high blood pressure and possibly other patients.
In particular, the dose-response findings highlight the need to keep staff and patients engaged in an intervention and to evaluate data in future studies. Lack of sustained effects in medication adherence and/or blood pressure control do not always mean that the intervention is ineffective or that it must be continued in all patients. The low rates of refill adherence among control group participants are a reminder of substantial gaps in hypertension care and the need to assess barriers to adherence before intensifying therapy (i.e., increasing the number of prescribed blood pressure drugs or dosage) for minority and low-income patients.
